Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations WL Bennett, NM Maruthur, S Singh, JB Segal, LM Wilson, R Chatterjee, ... Annals of internal medicine 154 (9), 602-613, 2011 | 836 | 2011 |
Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis NM Maruthur, E Tseng, S Hutfless, LM Wilson, C Suarez-Cuervo, Z Berger, ... Annals of internal medicine 164 (11), 740-751, 2016 | 816 | 2016 |
An expanded genome-wide association study of type 2 diabetes in Europeans RA Scott, LJ Scott, R Mägi, L Marullo, KJ Gaulton, M Kaakinen, ... Diabetes 66 (11), 2888-2902, 2017 | 729 | 2017 |
Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetes care 45 (11), 2753-2786, 2022 | 690 | 2022 |
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis HC Yeh, TT Brown, N Maruthur, P Ranasinghe, Z Berger, YD Suh, ... Annals of internal medicine 157 (5), 336-347, 2012 | 642 | 2012 |
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetologia 65 (12), 1925-1966, 2022 | 439 | 2022 |
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis E Wheeler, A Leong, CT Liu, MF Hivert, RJ Strawbridge, C Podmore, M Li, ... PLoS medicine 14 (9), e1002383, 2017 | 407 | 2017 |
Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial NM Maruthur, NY Wang, LJ Appel Circulation 119 (15), 2026-2031, 2009 | 345 | 2009 |
Gut microbiome and its role in obesity and insulin resistance CJ Lee, CL Sears, N Maruthur Annals of the New York Academy of Sciences 1461 (1), 37-52, 2020 | 279 | 2020 |
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility J Wessel, AY Chu, SM Willems, S Wang, H Yaghootkar, JA Brody, ... Nature communications 6 (1), 5897, 2015 | 228 | 2015 |
The association of obesity and cervical cancer screening: a systematic review and meta‐analysis NM Maruthur, SD Bolen, FL Brancati, JM Clark Obesity 17 (2), 375-381, 2009 | 221 | 2009 |
Obesity and mammography: a systematic review and meta-analysis NM Maruthur, S Bolen, FL Brancati, JM Clark Journal of general internal medicine 24, 665-677, 2009 | 163 | 2009 |
Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes R Qayyum, S Bolen, N Maruthur, L Feldman, LM Wilson, SS Marinopoulos, ... Annals of internal medicine 149 (8), 549-559, 2008 | 158 | 2008 |
Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death E Selvin, AM Rawlings, PL Lutsey, N Maruthur, JS Pankow, M Steffes, ... Circulation 132 (4), 269-277, 2015 | 153 | 2015 |
The effect of dietary patterns on estimated coronary heart disease risk: results from the Dietary Approaches to Stop Hypertension (DASH) trial ST Chen, NM Maruthur, LJ Appel Circulation: Cardiovascular Quality and Outcomes 3 (5), 484-489, 2010 | 144 | 2010 |
The pharmacogenetics of type 2 diabetes: a systematic review NM Maruthur, MO Gribble, WL Bennett, S Bolen, LM Wilson, ... Diabetes Care 37 (3), 876-886, 2014 | 133 | 2014 |
Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease A Tin, ME Grams, NM Maruthur, BC Astor, D Couper, TH Mosley, E Selvin, ... Kidney international 87 (4), 820-827, 2015 | 132 | 2015 |
Patient preferences for the treatment of type 2 diabetes: a scoping review SM Joy, E Little, NM Maruthur, TS Purnell, JFP Bridges Pharmacoeconomics 31, 877-892, 2013 | 129 | 2013 |
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease RA Scott, DF Freitag, L Li, AY Chu, P Surendran, R Young, N Grarup, ... Science translational medicine 8 (341), 341ra76-341ra76, 2016 | 124 | 2016 |
Chronic venous leg ulcer treatment: future research needs G Lazarus, MF Valle, M Malas, U Qazi, NM Maruthur, D Doggett, ... Wound repair and regeneration 22 (1), 34-42, 2014 | 108 | 2014 |